https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=Aldosteron
Aldosteron - Versionsgeschichte
2026-04-23T10:51:51Z
Versionsgeschichte dieser Seite in PlusPedia
MediaWiki 1.43.3
https://ddn.pluspedia.org/w/index.php?title=Aldosteron&diff=28449&oldid=prev
Ossip Groth am 21. Februar 2010 um 06:23 Uhr
2010-02-21T06:23:51Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 21. Februar 2010, 06:23 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Zeile 2:</td>
<td colspan="2" class="diff-lineno">Zeile 2:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><ref name="PMID18292466">A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 </ref><ref name="PMID15814845">The nongenomic actions of aldosterone. Endocr Rev 26(3):313-21 (2005) PMID 15814845 </ref><ref name="PMID11701424">Nontraditional aspects of aldosterone physiology. Am J Physiol Endocrinol Metab 281(6):E1122-7 (2001) PMID 11701424 </ref><ref name="PMID13240591">Aldosterone: a review. Can Med Assoc J 73(3):221-3 (1955) PMID 13240591 </ref><ref name="PMID17699271">Aldosterone antagonism in chronic kidney disease. Clin J Am Soc Nephrol 1(4):668-77 (2006) PMID 17699271 </ref><ref name="PMID15525873">Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy. Diabetes Metab 30(4):311-8 (2004) PMID 15525873 </ref><ref name="PMID17124364">Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J 54(4):487-95 (2007) PMID 17124364 </ref><ref name="PMID12746276">Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 144(6):2208-13 (2003) PMID 12746276 </ref><ref name="PMID15367532">Aldosterone blockade in cardiovascular disease. Heart 90(10):1229-34 (2004) PMID 15367532 </ref><ref name="PMID17309947">Nongenomic actions of aldosterone on the renal tubule. Hypertension 49(4):728-39 (2007) PMID 17309947 </ref><ref name="PMID16432039">Effects of aldosterone on the vasculature. Hypertension 47(3):312-8 (2006) PMID 16432039 </ref><ref name="PMID15007036">The many targets of aldosterone. Hypertension 43(5):938-40 (2004) PMID 15007036 </ref><ref name="PMID18552288">Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266-81 (2008) PMID 18552288 </ref><ref name="PMID18685118">A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 93(8):2972-4 (2008) PMID 18685118 </ref><ref name="PMID15483077">The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 90(1):72-8 (2005) PMID 15483077 </ref><ref name="PMID12915648">Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 88(8):3637-44 (2003) PMID 12915648 </ref><ref name="PMID12788831">Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 88(6):2376-83 (2003) PMID 12788831 </ref><ref name="PMID16002531">The new biology of aldosterone. J Endocrinol 186(1):1-20 (2005) PMID 16002531 </ref><ref name="PMID18651533">Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21(4):455-62 (2008) PMID 18651533 </ref><ref name="PMID18651532">Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21(4):447-54 (2008) PMID 18651532 </ref><ref name="PMID11571370">Hyperaldosteronism: recent concepts, diagnosis, and management. Postgrad Med J 77(912):639-44 (2001) PMID 11571370 </ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><ref name="PMID18292466">A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 </ref><ref name="PMID15814845">The nongenomic actions of aldosterone. Endocr Rev 26(3):313-21 (2005) PMID 15814845 </ref><ref name="PMID11701424">Nontraditional aspects of aldosterone physiology. Am J Physiol Endocrinol Metab 281(6):E1122-7 (2001) PMID 11701424 </ref><ref name="PMID13240591">Aldosterone: a review. Can Med Assoc J 73(3):221-3 (1955) PMID 13240591 </ref><ref name="PMID17699271">Aldosterone antagonism in chronic kidney disease. Clin J Am Soc Nephrol 1(4):668-77 (2006) PMID 17699271 </ref><ref name="PMID15525873">Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy. Diabetes Metab 30(4):311-8 (2004) PMID 15525873 </ref><ref name="PMID17124364">Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J 54(4):487-95 (2007) PMID 17124364 </ref><ref name="PMID12746276">Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 144(6):2208-13 (2003) PMID 12746276 </ref><ref name="PMID15367532">Aldosterone blockade in cardiovascular disease. Heart 90(10):1229-34 (2004) PMID 15367532 </ref><ref name="PMID17309947">Nongenomic actions of aldosterone on the renal tubule. Hypertension 49(4):728-39 (2007) PMID 17309947 </ref><ref name="PMID16432039">Effects of aldosterone on the vasculature. Hypertension 47(3):312-8 (2006) PMID 16432039 </ref><ref name="PMID15007036">The many targets of aldosterone. Hypertension 43(5):938-40 (2004) PMID 15007036 </ref><ref name="PMID18552288">Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266-81 (2008) PMID 18552288 </ref><ref name="PMID18685118">A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 93(8):2972-4 (2008) PMID 18685118 </ref><ref name="PMID15483077">The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 90(1):72-8 (2005) PMID 15483077 </ref><ref name="PMID12915648">Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 88(8):3637-44 (2003) PMID 12915648 </ref><ref name="PMID12788831">Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 88(6):2376-83 (2003) PMID 12788831 </ref><ref name="PMID16002531">The new biology of aldosterone. J Endocrinol 186(1):1-20 (2005) PMID 16002531 </ref><ref name="PMID18651533">Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21(4):455-62 (2008) PMID 18651533 </ref><ref name="PMID18651532">Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21(4):447-54 (2008) PMID 18651532 </ref><ref name="PMID11571370">Hyperaldosteronism: recent concepts, diagnosis, and management. Postgrad Med J 77(912):639-44 (2001) PMID 11571370 <ins style="font-weight: bold; text-decoration: none;"></ref><ref name="PMID15284285">Mechanisms of hypertension: the expanding role of aldosterone. J Am Soc Nephrol 15(8):1993-2001 (2004) PMID 15284285 </ref><ref name="PMID1405311">The cellular action of aldosterone in target epithelia. Kidney Int 42(2):250-64 (1992) PMID 1405311 </ins></ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td></tr>
</table>
Ossip Groth
https://ddn.pluspedia.org/w/index.php?title=Aldosteron&diff=28345&oldid=prev
Ossip Groth am 20. Februar 2010 um 22:47 Uhr
2010-02-20T22:47:55Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 20. Februar 2010, 22:47 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Zeile 2:</td>
<td colspan="2" class="diff-lineno">Zeile 2:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681"><del style="font-weight: bold; text-decoration: none;">. et al., </del>Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><ref name="PMID18292466"><del style="font-weight: bold; text-decoration: none;">. et al., </del>A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 </ref><ref name="PMID15814845"><del style="font-weight: bold; text-decoration: none;">. et al., </del>The nongenomic actions of aldosterone. Endocr Rev 26(3):313-21 (2005) PMID 15814845 </ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><ref name="PMID18292466">A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 </ref><ref name="PMID15814845">The nongenomic actions of aldosterone. Endocr Rev 26(3):313-21 (2005) PMID 15814845 <ins style="font-weight: bold; text-decoration: none;"></ref><ref name="PMID11701424">Nontraditional aspects of aldosterone physiology. Am J Physiol Endocrinol Metab 281(6):E1122-7 (2001) PMID 11701424 </ref><ref name="PMID13240591">Aldosterone: a review. Can Med Assoc J 73(3):221-3 (1955) PMID 13240591 </ref><ref name="PMID17699271">Aldosterone antagonism in chronic kidney disease. Clin J Am Soc Nephrol 1(4):668-77 (2006) PMID 17699271 </ref><ref name="PMID15525873">Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy. Diabetes Metab 30(4):311-8 (2004) PMID 15525873 </ref><ref name="PMID17124364">Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J 54(4):487-95 (2007) PMID 17124364 </ref><ref name="PMID12746276">Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 144(6):2208-13 (2003) PMID 12746276 </ref><ref name="PMID15367532">Aldosterone blockade in cardiovascular disease. Heart 90(10):1229-34 (2004) PMID 15367532 </ref><ref name="PMID17309947">Nongenomic actions of aldosterone on the renal tubule. Hypertension 49(4):728-39 (2007) PMID 17309947 </ref><ref name="PMID16432039">Effects of aldosterone on the vasculature. Hypertension 47(3):312-8 (2006) PMID 16432039 </ref><ref name="PMID15007036">The many targets of aldosterone. Hypertension 43(5):938-40 (2004) PMID 15007036 </ref><ref name="PMID18552288">Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(9):3266-81 (2008) PMID 18552288 </ref><ref name="PMID18685118">A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab 93(8):2972-4 (2008) PMID 18685118 </ref><ref name="PMID15483077">The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 90(1):72-8 (2005) PMID 15483077 </ref><ref name="PMID12915648">Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab 88(8):3637-44 (2003) PMID 12915648 </ref><ref name="PMID12788831">Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 88(6):2376-83 (2003) PMID 12788831 </ref><ref name="PMID16002531">The new biology of aldosterone. J Endocrinol 186(1):1-20 (2005) PMID 16002531 </ref><ref name="PMID18651533">Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21(4):455-62 (2008) PMID 18651533 </ref><ref name="PMID18651532">Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21(4):447-54 (2008) PMID 18651532 </ref><ref name="PMID11571370">Hyperaldosteronism: recent concepts, diagnosis, and management. Postgrad Med J 77(912):639-44 (2001) PMID 11571370 </ins></ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td></tr>
<tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l44">Zeile 44:</td>
<td colspan="2" class="diff-lineno">Zeile 44:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><references /></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><references /></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{LinkWP_Miniartikel}}</ins></div></td></tr>
</table>
Ossip Groth
https://ddn.pluspedia.org/w/index.php?title=Aldosteron&diff=21113&oldid=prev
Ossip Groth am 8. Januar 2010 um 21:07 Uhr
2010-01-08T21:07:25Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 8. Januar 2010, 21:07 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Zeile 2:</td>
<td colspan="2" class="diff-lineno">Zeile 2:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">. et al., Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><ref name="PMID18292466">. et al., A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 </ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">. et al., Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><ref name="PMID18292466">. et al., A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 <ins style="font-weight: bold; text-decoration: none;"></ref><ref name="PMID15814845">. et al., The nongenomic actions of aldosterone. Endocr Rev 26(3):313-21 (2005) PMID 15814845 </ins></ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td></tr>
</table>
Ossip Groth
https://ddn.pluspedia.org/w/index.php?title=Aldosteron&diff=21054&oldid=prev
Ossip Groth am 8. Januar 2010 um 19:52 Uhr
2010-01-08T19:52:36Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="de">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 8. Januar 2010, 19:52 Uhr</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Zeile 2:</td>
<td colspan="2" class="diff-lineno">Zeile 2:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">. et al., Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID15044681">. et al., Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 <ins style="font-weight: bold; text-decoration: none;"></ref><ref name="PMID18292466">. et al., A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133-54 (2008) PMID 18292466 </ins></ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td></tr>
</table>
Ossip Groth
https://ddn.pluspedia.org/w/index.php?title=Aldosteron&diff=20721&oldid=prev
Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel''' | align="left" width="800" |<re...“
2010-01-07T18:02:14Z
<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Pptpdtjpg1.png" title="Datei:Pptpdtjpg1.png">miniatur|Entstehender Artikel</a> {| class="wikitable" | | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel''' | align="left" width="800" |<re...“</p>
<p><b>Neue Seite</b></p><div>[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]<br />
{| class="wikitable" |<br />
| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''<br />
| align="left" width="800" |<ref name="PMID15044681">. et al., Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84(2):489-539 (2004) PMID 15044681 </ref><br />
|-<br />
| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Medline Suchterm/ Synonyme'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#00dfdf" | '''Was ist das'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Struktur'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Physiologie'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Knockout'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Transgen'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Mutation'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Polymorphismus'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Genexpression'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Inhibitoren'''<br />
| align="left" width="800"| <br />
|-<br />
| bgcolor="#dfdfdf" | '''Agonisten'''<br />
| align="left" width="800"| <br />
|}<br />
<br />
<br />
== Bibliographie ==<br />
<references /></div>
Ossip Groth